Stay updated on Fluticasone Propionate PMDI vs Flovent HFA Clinical Trial
Sign up to get notified when there's something new on the Fluticasone Propionate PMDI vs Flovent HFA Clinical Trial page.

Latest updates to the Fluticasone Propionate PMDI vs Flovent HFA Clinical Trial page
- CheckyesterdayChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page displays the ClinicalTrials.gov record for a completed Phase 3 study comparing fluticasone propionate inhaler with Flovent HFA and placebo in adults with asthma. It includes study design, participant criteria, outcome measures, locations, and record dates.SummaryDifference44%

- Check22 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov revision as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedA site-wide NIH announcement says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

Stay in the know with updates to Fluticasone Propionate PMDI vs Flovent HFA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fluticasone Propionate PMDI vs Flovent HFA Clinical Trial page.